cofrogliptin
Small moleculeexperimental
Clinical trial activity
2 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jul 30, 2025 (NCT07019012)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Dipeptidyl peptidase IVINHIBITOR
DPP4 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2- Mol. weight
- 466.43 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4646510 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07122102 | N/A | Oct 1, 2025 | Haisco Pharmaceutical |
| NCT07019012 | Phase 4 | Jul 30, 2025 | Huazhong University of Science and Technology, Nanchang University, Shiyan Taihe Hospital, Wuhan Central Hospital, Wuhan University, Xiang Yang NO.1 People's Hospital |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haisco Pharmaceutical | For profit | 1 | 1 | 1 | 2025 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Nanchang University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Shiyan Taihe Hospital | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Wuhan Central Hospital | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Wuhan University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Xiang Yang NO.1 People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2025 |
7 organizations
Page 1 / 1